Bank Of America Corp Portage Biotech Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.73 - $3.87 $248 - $352	-91 Reduced 24.93%	274 $0
Q1 2023 May 12, 2023	SELL	$2.6 - $7.2 $169 - $468	-65 Reduced 15.12%	365 $1,000
Q4 2022 Feb 10, 2023	SELL	$4.42 - $150.6 $2,152 - $73,342	-487 Reduced 53.11%	430 $2,000
Q3 2022 Nov 14, 2022	SELL	$6.81 - $136.4 $2,724 - $54,560	-400 Reduced 30.37%	917 $6,000
Q2 2022 Aug 12, 2022	SELL	$5.16 - $11.95 $9,607 - $22,250	-1,862 Reduced 58.57%	1,317 $9,000
Q1 2022 May 16, 2022	SELL	$6.57 - $12.0 $14,513 - $26,508	-2,209 Reduced 41.0%	3,179 $21,000
Q4 2021 Feb 08, 2022	BUY	$10.73 - $23.74 $13,444 - $29,746	1,253 Added 30.3%	5,388 $58,000
Q3 2021 Nov 15, 2021	BUY	$13.65 - $22.4 $31,941 - $52,416	2,340 Added 130.36%	4,135 $84,000
Q2 2021 Sep 13, 2021	BUY	$20.96 - $42.81 $37,623 - $76,843	1,795 New	1,795 $38,000

1.96M

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $117M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.